Overview
"I am an anesthesiologist and critical care doctor who takes care of the critically ill throughout the Duke Hospital System. My focus is to help patients return to their lives and to guide their families through these difficult times. I firmly believe that understanding a patient’s history, both clinically and personally, is important in treating them and to that end, I dedicate as much time as possible with patients and their loved ones, listening and learning about who they are as a person. A quote that helps guide my work is from Anatole Broyard who wrote about his own health condition that ""To most physicians, my illness is a routine incident in their rounds, while for me it's the crisis of my life. I would feel better if I had a doctor who at least perceived this incongruity."" I think it is important to remember this each day and each patient. I consider it a privilege to take care of patients and am dedicated to providing the highest-quality for those I see.".
His clinical expertise encompasses Muscle Invasive Bladder Cancer and Non-Muscle Invasive Bladder Cancer.
Dr. Mehdiratta is board certified in American Board Of Anesthesiology, General Anesthesiology and American Board Of Anesthesiology, Critical Care Medicine. He is actively involved in clinical research, co-authoring 12 peer reviewed articles. Dr. Mehdiratta is currently accepting new patients.
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- POS
- EPO
- HMO
- POS
- PPO
Locations
3400 Wake Forest Rd, Raleigh, NC 27609
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Rex Pulmonary Specialists-Raleigh
William Hall is an Intensive Care Medicine provider practicing medicine in Raleigh, North Carolina. Dr. Hall is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Lung Nodules, Emphysema, Nontuberculous Mycobacterial Lung Disease, and Pulmonary Fibrosis. Dr. Hall is currently accepting new patients.
Duke Regional Hospital
I am from Rockford, IL and I'm a general surgeon. I always thought I would be a cancer doctor but never a surgeon. It turns out I enjoyed operating. I enjoy the immediate gratification of surgical treatment whether it's removing an appendix, or fixing an incarcerated hernia. I love Durham, NC as does my wife and two children. We look forward to staying here for a very long time and being a part of this community. Dr. Fong is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Cholecystitis, Gallbladder Disease, End-Stage Renal Disease (ESRD), Gallbladder Removal, and Hernia Surgery. Dr. Fong is board certified in American Board Of Surgery, General Surgery and American Board Of Surgery, Surgical Critical Care . Dr. Fong is currently accepting new patients.
UT MD Anderson Cancer Center
Farzin Goravanchi is an Anesthesiologist practicing medicine in Cary, North Carolina. Dr. Goravanchi is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Upper Tract Urothelial Carcinoma (UTUC), Muscle Invasive Bladder Cancer, and Non-Muscle Invasive Bladder Cancer.
Frequently Asked Questions about Dr. Nitin L. Mehdiratta
How do I make an appointment with Dr. Nitin L. Mehdiratta?
You can book an appointment with Dr. Nitin L. Mehdiratta by calling their office at 919-954-3000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Nitin L. Mehdiratta a top-rated expert for Muscle Invasive Bladder Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Nitin L. Mehdiratta is classified as an Experienced expert for Muscle Invasive Bladder Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Nitin L. Mehdiratta specialize in?
While Dr. Nitin L. Mehdiratta is a Anesthesiology, they have specific expertise in Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Anesthesiology.
Does Dr. Nitin L. Mehdiratta participate in research or clinical trials?
Yes. Dr. Nitin L. Mehdiratta has published 12 articles and abstracts on conditions like Muscle Invasive Bladder Cancer. You can view a list of Dr. Nitin L. Mehdiratta's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Nitin L. Mehdiratta accept my insurance?
Dr. Nitin L. Mehdiratta accepts most major insurance plans, including Aetna and Ambetter. We recommend calling the office directly at 919-954-3000 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Muscle Invasive Bladder CancerDr. Mehdiratta isExperienced. Learn about Muscle Invasive Bladder Cancer.
- Non-Muscle Invasive Bladder CancerDr. Mehdiratta isExperienced. Learn about Non-Muscle Invasive Bladder Cancer.